Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings

Recommendations From AMDA's Infection Advisory Committee

David A. Nace, Laurie R. Archbald-Pannone, Muhammad Salman Ashraf, Paul J. Drinka, Elizabeth Frentzel, Swati Gaur, Dheeraj Mahajan, David R. Mehr, William C. Mercer, Philip D. Sloane, Robin L.P. Jump

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Efforts at preventing pneumococcal disease are a national health priority, particularly in older adults and especially in post-acute and long-term care settings The Advisory Committee on Immunization Practices recommends that all adults ≥65 years of age, as well as adults 18–64 years of age with specific risk factors, receive both the recently introduced polysaccharide-protein conjugate vaccine against 13 pneumococcal serotypes as well as the polysaccharide vaccine against 23 pneumococcal serotypes. Nursing facility licensure regulations require facilities to assess the pneumococcal vaccination status of each resident, provide education regarding pneumococcal vaccination, and administer the appropriate pneumococcal vaccine when indicated. Sorting out the indications and timing for 13 pneumococcal serotypes and 23 pneumococcal serotypes administration is complex and presents a significant challenge to healthcare providers. Here, we discuss the importance of pneumococcal vaccination for older adults, detail AMDA—The Society for Post-Acute and Long-Term Care Medicine (The Society)'s recommendations for pneumococcal vaccination practice and procedures, and offer guidance to postacute and long-term care providers supporting the development and effective implementation of pneumococcal vaccine policies.

Original languageEnglish (US)
Pages (from-to)99-104
Number of pages6
JournalJournal of the American Medical Directors Association
Volume18
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Long-Term Care
Advisory Committees
Vaccination
Pneumococcal Vaccines
Infection
Nursing Licensures
Polysaccharides
Facility Regulation and Control
Health Priorities
Conjugate Vaccines
Health Personnel
Immunization
Vaccines
Medicine
Education
Serogroup
Proteins

Keywords

  • Nursing home
  • aged
  • pneumococcal infections
  • pneumococcal vaccines
  • policy

ASJC Scopus subject areas

  • Nursing(all)
  • Health Policy
  • Geriatrics and Gerontology

Cite this

Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings : Recommendations From AMDA's Infection Advisory Committee. / Nace, David A.; Archbald-Pannone, Laurie R.; Ashraf, Muhammad Salman; Drinka, Paul J.; Frentzel, Elizabeth; Gaur, Swati; Mahajan, Dheeraj; Mehr, David R.; Mercer, William C.; Sloane, Philip D.; Jump, Robin L.P.

In: Journal of the American Medical Directors Association, Vol. 18, No. 2, 01.02.2017, p. 99-104.

Research output: Contribution to journalArticle

Nace, DA, Archbald-Pannone, LR, Ashraf, MS, Drinka, PJ, Frentzel, E, Gaur, S, Mahajan, D, Mehr, DR, Mercer, WC, Sloane, PD & Jump, RLP 2017, 'Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings: Recommendations From AMDA's Infection Advisory Committee', Journal of the American Medical Directors Association, vol. 18, no. 2, pp. 99-104. https://doi.org/10.1016/j.jamda.2016.11.010
Nace, David A. ; Archbald-Pannone, Laurie R. ; Ashraf, Muhammad Salman ; Drinka, Paul J. ; Frentzel, Elizabeth ; Gaur, Swati ; Mahajan, Dheeraj ; Mehr, David R. ; Mercer, William C. ; Sloane, Philip D. ; Jump, Robin L.P. / Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings : Recommendations From AMDA's Infection Advisory Committee. In: Journal of the American Medical Directors Association. 2017 ; Vol. 18, No. 2. pp. 99-104.
@article{c3a69f630a454e45b056d0489efd53c5,
title = "Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings: Recommendations From AMDA's Infection Advisory Committee",
abstract = "Efforts at preventing pneumococcal disease are a national health priority, particularly in older adults and especially in post-acute and long-term care settings The Advisory Committee on Immunization Practices recommends that all adults ≥65 years of age, as well as adults 18–64 years of age with specific risk factors, receive both the recently introduced polysaccharide-protein conjugate vaccine against 13 pneumococcal serotypes as well as the polysaccharide vaccine against 23 pneumococcal serotypes. Nursing facility licensure regulations require facilities to assess the pneumococcal vaccination status of each resident, provide education regarding pneumococcal vaccination, and administer the appropriate pneumococcal vaccine when indicated. Sorting out the indications and timing for 13 pneumococcal serotypes and 23 pneumococcal serotypes administration is complex and presents a significant challenge to healthcare providers. Here, we discuss the importance of pneumococcal vaccination for older adults, detail AMDA—The Society for Post-Acute and Long-Term Care Medicine (The Society)'s recommendations for pneumococcal vaccination practice and procedures, and offer guidance to postacute and long-term care providers supporting the development and effective implementation of pneumococcal vaccine policies.",
keywords = "Nursing home, aged, pneumococcal infections, pneumococcal vaccines, policy",
author = "Nace, {David A.} and Archbald-Pannone, {Laurie R.} and Ashraf, {Muhammad Salman} and Drinka, {Paul J.} and Elizabeth Frentzel and Swati Gaur and Dheeraj Mahajan and Mehr, {David R.} and Mercer, {William C.} and Sloane, {Philip D.} and Jump, {Robin L.P.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.jamda.2016.11.010",
language = "English (US)",
volume = "18",
pages = "99--104",
journal = "Journal of the American Medical Directors Association",
issn = "1525-8610",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings

T2 - Recommendations From AMDA's Infection Advisory Committee

AU - Nace, David A.

AU - Archbald-Pannone, Laurie R.

AU - Ashraf, Muhammad Salman

AU - Drinka, Paul J.

AU - Frentzel, Elizabeth

AU - Gaur, Swati

AU - Mahajan, Dheeraj

AU - Mehr, David R.

AU - Mercer, William C.

AU - Sloane, Philip D.

AU - Jump, Robin L.P.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Efforts at preventing pneumococcal disease are a national health priority, particularly in older adults and especially in post-acute and long-term care settings The Advisory Committee on Immunization Practices recommends that all adults ≥65 years of age, as well as adults 18–64 years of age with specific risk factors, receive both the recently introduced polysaccharide-protein conjugate vaccine against 13 pneumococcal serotypes as well as the polysaccharide vaccine against 23 pneumococcal serotypes. Nursing facility licensure regulations require facilities to assess the pneumococcal vaccination status of each resident, provide education regarding pneumococcal vaccination, and administer the appropriate pneumococcal vaccine when indicated. Sorting out the indications and timing for 13 pneumococcal serotypes and 23 pneumococcal serotypes administration is complex and presents a significant challenge to healthcare providers. Here, we discuss the importance of pneumococcal vaccination for older adults, detail AMDA—The Society for Post-Acute and Long-Term Care Medicine (The Society)'s recommendations for pneumococcal vaccination practice and procedures, and offer guidance to postacute and long-term care providers supporting the development and effective implementation of pneumococcal vaccine policies.

AB - Efforts at preventing pneumococcal disease are a national health priority, particularly in older adults and especially in post-acute and long-term care settings The Advisory Committee on Immunization Practices recommends that all adults ≥65 years of age, as well as adults 18–64 years of age with specific risk factors, receive both the recently introduced polysaccharide-protein conjugate vaccine against 13 pneumococcal serotypes as well as the polysaccharide vaccine against 23 pneumococcal serotypes. Nursing facility licensure regulations require facilities to assess the pneumococcal vaccination status of each resident, provide education regarding pneumococcal vaccination, and administer the appropriate pneumococcal vaccine when indicated. Sorting out the indications and timing for 13 pneumococcal serotypes and 23 pneumococcal serotypes administration is complex and presents a significant challenge to healthcare providers. Here, we discuss the importance of pneumococcal vaccination for older adults, detail AMDA—The Society for Post-Acute and Long-Term Care Medicine (The Society)'s recommendations for pneumococcal vaccination practice and procedures, and offer guidance to postacute and long-term care providers supporting the development and effective implementation of pneumococcal vaccine policies.

KW - Nursing home

KW - aged

KW - pneumococcal infections

KW - pneumococcal vaccines

KW - policy

UR - http://www.scopus.com/inward/record.url?scp=85010408120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010408120&partnerID=8YFLogxK

U2 - 10.1016/j.jamda.2016.11.010

DO - 10.1016/j.jamda.2016.11.010

M3 - Article

VL - 18

SP - 99

EP - 104

JO - Journal of the American Medical Directors Association

JF - Journal of the American Medical Directors Association

SN - 1525-8610

IS - 2

ER -